Education
About Us
Working with TipRanks
Follow Us
Gelion PLC (GB:GELN)
LSE:GELN
GELN Stock Chart & Stats
18.50 p
1.00 p(6.25%)
At close: 4:00 PM EST
18.50 p
1.00 p(6.25%)
Day’s Range― - ―
52-Week Range9.20 p - 30.00 p
Previous CloseN/A
Volume5.00K
Average Volume (3M)395.75K
Market Cap
£37.85M
Enterprise Value19.16M
Total Cash (Recent Filing)£10.52M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta-0.35
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding229,421,460
10 Day Avg. Volume121,404
30 Day Avg. Volume395,753
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)3.53
Price to Sales (P/S)38.63
P/FCF Ratio-7.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExtremely low leverage materially reduces solvency and refinancing risk, giving Gelion flexibility to pursue scale-up investments and absorb operating losses. This balance-sheet conservatism supports a longer runway to commercialisation without reliance on costly debt.
Validated Partner PrototypingSuccessful prototyping with TDK and QinetiQ provides external technical validation of Gelion's NES chemistry and cross-team material transfer. These partnerships de-risk the technology, accelerate product development, and improve prospects for third-party manufacturing and customer adoption.
Non-dilutive Funding & Improved EBITDAIncreased government grant funding and a reduction in adjusted EBITDA loss show improved funding mix and cost control. Non-dilutive capital plus IP filings and advisor additions extend runway and allow focused capex on scale-up while limiting shareholder dilution risk.
Bears Say
Persistent Cash BurnOperating and free cash flows remain significantly negative, indicating ongoing burn that requires external funding until revenues scale. Persistent cash outflows constrain strategic flexibility, elevate dilution risk, and make near-term survival sensitive to grant and investor funding availability.
Delayed Commercial RevenueThe Integration division has a long sales cycle and management defers expected revenue to 2027+, delaying the company's path to breakeven. This extends dependence on funding, increases time to positive unit economics, and heightens exposure to execution risk over multiple quarters.
Manufacturing & Technical RisksPrototype processes require process-engineering to improve yields and component utilisation, while full-cell calendar life remains unvalidated. These technical and manufacturing gaps directly affect unit economics, scalability and time-to-market, keeping commercial outcomes highly uncertain.
Gelion PLC News
GELN FAQ
What was Gelion PLC’s price range in the past 12 months?
Gelion PLC lowest share price was 9.20 p and its highest was 30.00 p in the past 12 months.
What is Gelion PLC’s market cap?
Gelion PLC’s market cap is £37.85M.
When is Gelion PLC’s upcoming earnings report date?
Gelion PLC’s upcoming earnings report date is Nov 11, 2026 which is in 235 days.
How were Gelion PLC’s earnings last quarter?
Gelion PLC released its earnings results on Mar 02, 2026. The company reported -0.017 p earnings per share for the quarter, missing the consensus estimate of N/A by -0.017 p.
Is Gelion PLC overvalued?
According to Wall Street analysts Gelion PLC’s price is currently Overvalued.
Does Gelion PLC pay dividends?
Gelion PLC does not currently pay dividends.
What is Gelion PLC’s EPS estimate?
Gelion PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gelion PLC have?
Gelion PLC has 229,421,460 shares outstanding.
What happened to Gelion PLC’s price movement after its last earnings report?
Gelion PLC reported an EPS of -0.017 p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8.333%.
Which hedge fund is a major shareholder of Gelion PLC?
Currently, no hedge funds are holding shares in GB:GELN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Gelion PLC Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.31%
12-Months-Change
Fundamentals
Return on Equity
-42.23%
Trailing 12-Months
Asset Growth
59.13%
Trailing 12-Months
Company Description
Gelion PLC
Gelion plc engages in the research and development, design, manufacture, and sale of battery systems in the United Kingdom and internationally. The company offers zinc-bromide batteries under the Endure name. Its products are used in various applications, which include industrial light towers, solar and wind farms, desalination plants, mining pumps, passenger and heavy vehicles, electric buses and trains, and irrigation systems and other agricultural applications, as well as used by commercial and industrial enterprises and grid operators. The company was incorporated in 2015 and is headquartered in Eveleigh, Australia.
Technical Analysis
Options Prices
Currently, No data available
---